Dilip Harindran Vallathol

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 337 citations

Medicine, Oncology, Radiation Oncology +14

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort

Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol et al. · The Breast · 2022 · 14 citations · Full text

Medicine, Biostatistics, Oncology +16

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma

Gunjesh Kumar Singh, Hollis Dsouza, Nandini Menon et al. · ecancermedicalscience · 2021 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy

Vijay Patil, Nikhil Pande, Arun Chandrasekharan et al. · CNS Oncology · 2018 · 10 citations · Full text

Medicine, Neurosurgery, Oncology +17